Healthcare IBD - Summary & Resources
####WSO resources
[Healthcare Overview](https://www.wallstreetoasis.com/forums/healthcare…)
[Biotech Finance: From IB to VC / HF to Funded Startup (Part 1)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Biotech Finance: Valuation Methodologies And Modeling Considerations (Part 2)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Q&A: BB IBD Healthcare Analyst](https://www.wallstreetoasis.com/forums/q&a-bb-ibd…)
[Questions About Healthcare M&A](https://www.wallstreetoasis.com/forums/questions-…)
[Guide to Evaluate a Biotech Company](https://www.wallstreetoasis.com/forums/guide-to-e…)
####External resources (news and reports)
[FierceBiotech](https://www.fiercebiotech.com/)
[FiercePharma](https://www.fiercepharma.com/)
[Biospace](https://www.biospace.com/news/)
[WSJ Health](https://www.wsj.com/news/business/health-industry)
[Medscape](https://www.medscape.com/)
[Bain's Global Healthcare Private Equity and Corporate M&A reports][]
[Paul Keckley's weekly report](https://www.paulkeckley.com/the-keckley-report)
[Axios Vitals](https://www.axios.com/newsletters/axios-vitals)
Medical device industry:
[Fierce MedTech](https://www.fiercebiotech.com/medtech)
[MassDevice](https://www.massdevice.com/)
[Medical Device Manufacturers Association](https://www.medicaldevices.org/news/)
####Books
**- "The Pharmagellan Guide to Biotech Forecasting and Valuation"**
**- "Biotechnology Valuation", Karl Kleegan**: Chapter 3 is about the drug development process. You can also check Chapter 4 to learn how to build a disease model. However, read this book only if you already know valuation (DCF, comps), because the author uses quick-n-dirty or overly complex techniques that you shouldn't follow as an investment banker (he was an ER guy).
####Graphic on the industry
!PHARMA(https://www.wallstreetoasis.com/files/styles/w800…)
####Bonus videos
*How To Analyze a Clinical Trial:* not directly related to IB, but still interesting in order to understand how clinical trials work and the effect of their results on share price
[Part 1](
[Part 2](https://www.youtube.com/watch?v=A-hYVtCA06c)
[Part 3]()
[Part 4](https://www.youtube.com/watch?v=_aO5BhyEgXo)
Anything I should add?
**Thanks to TheFlyingKiwi(https://www.wallstreetoasis.com/user/423544)!**
[Bain's Global Healthcare Private Equity and Corporate M&A reports]: https://www.bain.com/insights/topics/global-healt…
[Medscape]: https://www.medscape.com/
Solid thread. +1 and following.
I'd add https://www.paulkeckley.com/the-keckley-report</a">Paul Keckley's weekly report to the ex resources. He does great political analysis and provides insight from government and survey data.
https://www.medscape.com/</a">Medscape
https://www.fiercebiotech.com/medtech</a">Fierce MedTech
https://www.massdevice.com/</a">Mass Device
WSJ Health
https://www.medicaldevices.org/news/</a">Med Dev Manufacturers Assoc (I just follow the Twitter account)
WSO:
https://www.wallstreetoasis.com/forums/biotech-finance-part-2-valuation…</a">Biotech Finance Part 2: Valuation Methodologies And Modeling Considerations
https://www.wallstreetoasis.com/forums/guide-to-evaluate-a-biotech-comp…</a">Guide To Evaluate A Biotech Company
Nice graphic on the industry.
Can't think of anymore off the top of my head. Looking forward to what others say as well.
I'm adding your links, thanks!
Cheers! Would be interested if other users follow any individual Twitter accounts that posts good insights/knowledge. Always hard to find those.
bump
bump
bump
bump
Bump
Bump
Bump
Bump
Bump
https://www.mobihealthnews.com/
I work in HCIT corporate right now and read a lot from this website as well as CB Insights Digital Health (very solid). Pretty sure HW or HL has a public report about HCIT companies in 2020 (fairly in depth, similar to CB Insights).
Associate exit opps?
bump
Bump
wondering if anyone has any good healthcare business books?
Bump
B
B
Optio error sit omnis est. Aut dolores molestias magni. Ut culpa et vel laboriosam unde at. Rerum maiores ipsum quas perferendis ab.
Aliquid sapiente iste ipsa eos mollitia vel. Nulla est temporibus aperiam et reiciendis quod. Deserunt atque corporis iste quia molestiae pariatur eum quis. Voluptatem nesciunt quia et sunt laudantium aperiam. Saepe voluptatem modi temporibus qui animi corporis qui.
Culpa ipsum reiciendis id. Optio placeat non distinctio. Tempora soluta sint sint sit. Molestiae veniam omnis dolore veniam et veritatis odit tempore. Dolor unde ratione officia quo quibusdam aut. Ipsum iure voluptas suscipit officia asperiores quibusdam. Eum magni consectetur repellendus esse.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
A exercitationem error qui possimus. Aut alias natus corporis quo magni. Impedit rerum nobis ut itaque iste.
Placeat non est beatae natus et non. Enim tempore et soluta. Omnis inventore tempora quia corrupti est numquam. Necessitatibus voluptatum aut et rerum porro quia.